Evidence map›Paper›PMID 41920999›Full record

ArticleScience advances2026

Copper deficiency impairs oligodendrocyte maturation and social behavior via mitophagy and mTOR suppression in ASD.

Noriyoshi Usui, Miyuki Doi, Stefano Berto, Kiwamu Matsuoka, Rio Ishida, Hana Miyauchi, Yuuki Fujiwara, Koichiro Irie, Michihiro Toritsuka, Takahira Yamauchi and 12 more

Abstract read
In one paragraph

Article in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Noriyoshi UsuiDepartment of Developmental Neuroscience, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.ORCID 0000-0001-8079-8013
Miyuki DoiDepartment of Developmental Neuroscience, Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.ORCID 0009-0007-9847-1861
Stefano BertoDepartment of Neuroscience, Medical University of South Carolina, Charleston, SC 29403, USA.ORCID 0000-0001-9028-9458
Kiwamu MatsuokaDepartment of Psychiatry, Nara Medical University, Nara 634-8522, Japan.ORCID 0000-0002-9730-5956
Rio IshidaDepartment of Psychiatry, Nara Medical University, Nara 634-8522, Japan.
Hana MiyauchiDepartment of Neuroscience and Cell Biology, Graduate School of Medicine, The University of Osaka, Suita 565-0871, Japan.
Yuuki FujiwaraUnited Graduate School of Child Development, The University of Osaka, Suita 565-0871, Japan.ORCID 0000-0003-1032-7755
Koichiro IrieDepartment of Neuroscience and Cell Biology, Graduate School of Medicine, The University of Osaka, Suita 565-0871, Japan.ORCID 0000-0001-7682-1321
Michihiro ToritsukaDivision of Transformative Psychiatry and Synergistic Research, International Center for Brain Sciences, Fujita Health University, Aichi 470-1192, Japan.
Takahira YamauchiDepartment of Psychiatry, Nara Medical University, Nara 634-8522, Japan.ORCID 0000-0001-9402-5062
Takaharu HiraiDepartment of Psychiatric and Mental Health Nursing, School of Nursing, University of Fukui, Fukui 910-1193, Japan.ORCID 0000-0002-3307-8109
Min-Jue XieUnited Graduate School of Child Development, The University of Osaka, Suita 565-0871, Japan.
Yoshinori KayashimaDepartment of Psychiatry, Nara Medical University, Nara 634-8522, Japan.
Naoko UmedaDivision of Development of Mental Functions, Research Center for Child Mental Development, University of Fukui, Fukui 910-1193, Japan.ORCID 0009-0006-6060-3681
Keiko IwataUnited Graduate School of Child Development, The University of Osaka, Suita 565-0871, Japan.
Kazuki OkumuraDepartment of Psychiatry, Nara Medical University, Nara 634-8522, Japan.ORCID 0000-0002-3019-7049
Taeko HaradaResearch Center for Child Mental Development, Hamamatsu University School of Medicine, Hamamatsu 431-3192, Japan.ORCID 0000-0002-7054-9715
Taiichi KatayamaUnited Graduate School of Child Development, The University of Osaka, Suita 565-0871, Japan.
Masatsugu TsujiiSchool of Contemporary Sociology, Chukyo University, Aichi 470-0393, Japan.
Hideo MatsuzakiUnited Graduate School of Child Development, The University of Osaka, Suita 565-0871, Japan.ORCID 0000-0002-6869-1261
Manabu MakinodanDivision of Transformative Psychiatry and Synergistic Research, International Center for Brain Sciences, Fujita Health University, Aichi 470-1192, Japan.
Shoichi ShimadaDepartment of Neuroscience and Cell Biology, Graduate School of Medicine, The University of Osaka, Suita 565-0871, Japan.ORCID 0000-0001-5369-1069

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Autism spectrum disorder (ASD) is a neurodevelopmental condition characterized by impaired social communication and restricted repetitive behaviors, yet the contribution of trace elements remains poorly defined. We profiled 21 trace elements in individuals with ASD and identified significantly reduced copper levels, which negatively correlated with social symptom severity. Magnetic resonance imaging revealed decreased white matter volume in ASD, which also correlated with social impairment. To explore the mechanisms, we generated a copper-deficient mouse model that displayed ASD-like behaviors and impaired oligodendrocyte (OL) development. Copper deficiency disrupted hypoxia-inducible factor 1α (HIF1α)-dependent angiogenesis and metabolic regulation in the embryonic brain, leading to oxidative stress, mitochondrial dysfunction, and BCL2 interacting protein 3 (BNIP3)-mediated mitophagy in oligodendrocyte progenitor cells. These processes suppressed mechanistic target of rapamycin kinase (mTOR) signaling, reduced OL-lineage cells, and caused hypomyelination. Restoring mTOR activity rescued OL maturation and improved social behavior in copper-deficient mice. These findings identify a copper-HIF1α-BNIP3-mTOR signaling axis that links trace element imbalance to glial dysfunction and ASD-relevant behavioral phenotypes, providing mechanistic insight into neurodevelopment.

Indexed as

Autism Spectrum DisorderCopperMitophagyOligodendrogliaSocial BehaviorTOR Serine-Threonine KinasesAnimalsDisease Models, AnimalFemaleHumansHypoxia-Inducible Factor 1, alpha SubunitMaleMiceSignal TransductionWhite MatterCopperHypoxia-Inducible Factor 1, alpha SubunitmTOR protein, mouseTOR Serine-Threonine Kinases

Identifiers

PMID41920999
PMCPMC13041773

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.